The Iliac/SFA/Popliteal Center

Filter Your Results

 

News

 

Cilostazol After DES Studied in Femoropopliteal Lesions

January 11, 2017 -- A study of cilostazol treatment after drug-eluting stent (DES) procedures for femoropopliteal lesions showed a reduction of stent restenosis in patients wi…

Optical Frequency Domain Imaging Compares Vascular Response of BMS Versus DES in SFA

January 11, 2017 -- An investigation of differences in vascular response between self-expanding nitinol bare-metal stents (BMSs) and nitinol paclitaxel-eluting stents (PESs) i…

SoundBite’s Shockwire Guidewire First-in-Human Procedure Successful

December 27, 2016­ -- SoundBite Medical Solutions Inc. announced it has completed its first-in-human procedure using shockwave energy to successfully and safely cross…

FDA Clears Avinger's Lightbox Touchscreen Vessel Measurement Function

December 22, 2016 -- Avinger, Inc. announced that the company has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Lightbox L250 imaging c…

Full Approval Granted for Pivotal Trial of QT Vascular's Chocolate Touch Drug-Coated Balloon

December 16, 2016 -- QT Vascular Ltd. announced that the US Food and Drug Administration (FDA) has granted full approval of the investigational device exemption to enroll pati…

Interim BIOFLEX PEACE Data Presented for Biotronik’s Pulsar-18 Stent in SFA Treatment

November 23, 2016 -- Biotronik announced that interim data from the BIOFLEX PEACE all-comers trial, which confirm the efficacy of the company’s Pulsar-18 bare-metal, sel…

Spectranetics’ Stellarex 0.014-Inch DCB Approved in Europe

November 21, 2016 -- The Spectranetics Corporation announced that the company’s Stellarex 0.014-inch drug-coated balloon (DCB) has received European CE Mark approval. …

Financing Will Advance Development of Shockwave Medical’s Lithoplasty Treatment

November 22, 2016 -- Shockwave Medical, a developer of treatments for calcified cardiovascular disease, announced the closing of $45 million in Series C financing led by Secto…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.